Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

Chen, A. C., Martin, M. M., Burr, L., Hasnain, S. Z., Lourie, R., Bowler, S. D., McGuckin, M. A. and Serisier, D. J. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. In: American Journal of Respiratory and Critical Care Medicine. , , (). .

Author Chen, A. C.
Martin, M. M.
Burr, L.
Hasnain, S. Z.
Lourie, R.
Bowler, S. D.
McGuckin, M. A.
Serisier, D. J.
Title of paper Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects
Proceedings title American Journal of Respiratory and Critical Care Medicine   Check publisher's open access policy
Journal name American Journal of Respiratory and Critical Care Medicine   Check publisher's open access policy
Publisher AMER THORACIC SOC
Publication Year 2013
Sub-type Published abstract
ISSN 1073-449X
Volume 187
Total pages 2
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Sub-type: Published abstract
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 16 Dec 2017, 01:00:40 EST by Web Cron on behalf of Learning and Research Services (UQ Library)